These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 329423)

  • 1. Effect of delta-9-tetrahydrocannabinol on intraocular pressure in humans.
    Cooler P; Gregg JM
    South Med J; 1977 Aug; 70(8):951-4. PubMed ID: 329423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of intravenous tetrahydrocannabinol on experimental and surgical pain. Psychological correlates of the analgesic response.
    Raft D; Gregg J; Ghia J; Harris L
    Clin Pharmacol Ther; 1977 Jan; 21(1):26-33. PubMed ID: 832447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marijuana: dose-response effects on pulse rate, subjective estimates of potency, pleasantness, and recognition memory.
    Miller L; Cornett T; Drew W; McFarland D; Brightwell D; Wikler A
    Pharmacology; 1977; 15(3):268-75. PubMed ID: 325580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the pharmacological activity of delta 9-tetrahydrocannabinol and its monohydroxylated metabolites in man.
    Perez-Reyes M; Timmons MC; Lipton MA; Christensen HD; Davis KH; Wall ME
    Experientia; 1973 Aug; 29(8):1009-10. PubMed ID: 4582081
    [No Abstract]   [Full Text] [Related]  

  • 5. Delta(9)-tetrahydrocannabinol,, euphoria and intraocular pressure in man.
    Purnell WD; Gregg JM
    Ann Ophthalmol; 1975 Jul; 7(7):921-3. PubMed ID: 1147519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of delta 9-tetrahydrocannabinol on intraocular pressure in the anaesthetized cat.
    Innemee HC; Hermans AJ; van Zwieten PA
    Doc Ophthalmol; 1980 Apr; 48(2):235-41. PubMed ID: 6249559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analgesic effect of delta-9-tetrahydrocannabinol.
    Noyes R; Brunk SF; Baram DA; Canter A
    J Clin Pharmacol; 1975; 15(2-3):139-43. PubMed ID: 1091664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology of the intraocular pressure (IOP) lowering effect of systemic dexanabinol (HU-211), a non-psychotropic cannabinoid.
    Beilin M; Neumann R; Belkin M; Green K; Bar-Ilan A
    J Ocul Pharmacol Ther; 2000 Jun; 16(3):217-30. PubMed ID: 10872919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous injection in man of 9 -tetrahydrocannabinol and 11-OH- 9 -tetrahydrocannabinol.
    Perez-Reyes M; Timmons MC; Lipton MA; Davis KH; Wall ME
    Science; 1972 Aug; 177(4049):633-5. PubMed ID: 4558903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical delta 9-tetrahydrocannabinol in hypertensive glaucomas.
    Merritt JC; Olsen JL; Armstrong JR; McKinnon SM
    J Pharm Pharmacol; 1981 Jan; 33(1):40-1. PubMed ID: 6114151
    [No Abstract]   [Full Text] [Related]  

  • 11. 11-hydroxy- 9 -tetrahydrocannabinol: pharmacology, disposition, and metabolism of a major metabolite of marihuana in man.
    Lemberger L; Crabtree RE; Rowe HM
    Science; 1972 Jul; 177(4043):62-4. PubMed ID: 5041775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic effects and physiologic disposition of delta 6a,10a dimethyl heptyl tetrahydrocannabinol (DMHP) in man.
    Lemberger L; McMahon R; Archer R; Matsumoto K; Rowe H
    Clin Pharmacol Ther; 1974 Apr; 15(4):380-6. PubMed ID: 4821441
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of the pharmacological activity in man of intravenously administered delta9-tetrahydrocannabinol, cannabinol, and cannabidiol.
    Perez-Reyes M; Timmons MC; Davis KH; Wall EM
    Experientia; 1973 Nov; 29(11):1368-9. PubMed ID: 4761242
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of cannabidiol on delta-9-tetrahydrocannabinol effects.
    Dalton WS; Martz R; Lemberger L; Rodda BE; Forney RB
    Clin Pharmacol Ther; 1976 Mar; 19(3):300-9. PubMed ID: 770048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spinal mechanisms of delta 9-tetrahydrocannabinol-induced analgesia.
    Smith PB; Martin BR
    Brain Res; 1992 Apr; 578(1-2):8-12. PubMed ID: 1324767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiologic observations in a controlled clinical trial of the antiemetic effectiveness of 5, 10, and 15 mg of delta 9-tetrahydrocannabinol in cancer chemotherapy. Ophthalmologic implications.
    Levitt M; Wilson A; Bowman D; Kemel S; Krepart G; Marks V; Schipper H; Thomson G; Weinerman B; Weinerman R
    J Clin Pharmacol; 1981; 21(S1):103S-109S. PubMed ID: 6271814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular effects of cannabinol during oral surgery.
    Gregg JM; Campbell RL; Levin KJ; Ghia J; Elliott RA
    Anesth Analg; 1976; 55(2):203-13. PubMed ID: 769605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diazepam (valium) as an adjunct in obstetric analgesia.
    Flowers CE; Rudolph AJ; Desmond MM
    Obstet Gynecol; 1969 Jul; 34(1):68-81. PubMed ID: 4893002
    [No Abstract]   [Full Text] [Related]  

  • 19. Multiple-drop study of topically applied 1% delta 9-tetrahydrocannabinol in human eyes.
    Jay WM; Green K
    Arch Ophthalmol; 1983 Apr; 101(4):591-3. PubMed ID: 6301412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of delta 9-tetrahydrocannabinol on intraocular pressure after removal of autonomic input.
    Colasanti BK; Powell SR
    J Ocul Pharmacol; 1985; 1(1):47-57. PubMed ID: 2851632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.